Cara Therapeutics Inc

NASDAQ:CARA   12:59:37 PM EDT
14.94
-0.11 (-0.73%)
Other Pre-Announcement

Cara Therapeutics Reports Q3 Loss Per Share $0.35

Published: 11/09/2020 21:54 GMT
Cara Therapeutics Inc (CARA) - Cara Therapeutics Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.35.
Q3 Revenue $9.3 Million Versus $5.8 Million.
Q3 Revenue Estimate $4.8 Million -- Refinitiv Ibes Data (analyst estimates).
Q3 Earnings per Share Estimate $-0.60 -- Refinitiv Ibes Data (analyst estimates).
at September 30, 2020, Cash and Cash Equivalents and Marketable Securities Totaled $131.4 Million.
Cara Therapeutics - Sees Existing Cash, Equivalents As of Sept 30, to Be Sufficient to Fund Currently Anticipated Operating Expenses, Capex Into 2023.